Open access · CC-BY
via OpenAlex
Rapamycin suppresses brain aging in senescence-accelerated OXYS rats
Nataliya G. Kolosova, Anton O. Vitovtov, Natalia A. Muraleva, Акулов Андрей Евгеньевич, Natalia A. Stefanova, Mikhail V. Blagosklonny
Aging · 2013 · ▲ 65 citations
Deregulated nutrient-sensing
Cellular senescence
Rapamycin / mTOR inhibition
Rat
Human
Mouse
Drosophila
Abstract
Cellular and organismal aging are driven in part by the MTOR(definition) (mechanistic target of rapamycin(definition)) pathway and rapamycin extends life span inC elegans, Drosophila and mice. Herein, we investigated effects of rapamycin on brain aging in OXYS rats. Previously we found, in OXYS rats, an early development of age-associated pathological phenotypes similar to several geriatric disorders in humans, including cerebral dysfunctions. Behavioral alterations as well as learning and memory deficits develop by 3 months. Here we show that rapamycin treatment (0.1 or 0.5 mg/kg as a food mixture daily from the age of 1.5 to 3.5 months) decreased anxiety and improved locomotor and exploratory behavior in OXYS rats. In untreated OXYS rats, MRI revealed an increase of the area of hippocampus, substantial hydrocephalus and 2-fold increased area of the lateral ventricles. Rapamycin treatment prevented these abnormalities, erasing the difference between OXYS and Wister rats (used as control). All untreated OXYS rats showed signs of neurodegeneration, manifested by loci of demyelination. Rapamycin decreased the percentage of animals with demyelination and the number of loci. Levels of Tau and phospho-Tau (T181) were increased in OXYS rats (compared with Wistar). Rapamycin significantly decreased Tau and inhibited its phosphorylation in the hippocampus of OXYS and Wistar rats. Importantly, rapamycin treatment caused a compensatory increase in levels of S6 and correspondingly levels of phospo-S6 in the frontal cortex, indicating that some downstream events were compensatory preserved, explaining the lack of toxicity. We conclude that rapamycin in low chronic doses can suppress brain aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/aging.100573
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Kolosova, N.G., Vitovtov, A.O., Muraleva, N.A., Евгеньевич, �.�., Stefanova, N.A., & Blagosklonny, M.V. (2013). Rapamycin suppresses brain aging in senescence-accelerated OXYS rats. <em>Aging</em>. https://doi.org/10.18632/aging.100573
Vancouver
Kolosova NG, Vitovtov AO, Muraleva NA, Евгеньевич ��, Stefanova NA, Blagosklonny MV. Rapamycin suppresses brain aging in senescence-accelerated OXYS rats. Aging. 2013. doi:10.18632/aging.100573.
BibTeX
@article{nataliya2013Rapamy,
title = {Rapamycin suppresses brain aging in senescence-accelerated OXYS rats},
author = {Nataliya G. Kolosova and Anton O. Vitovtov and Natalia A. Muraleva and Акулов Андрей Евгеньевич and Natalia A. Stefanova and Mikhail V. Blagosklonny},
journal = {Aging},
year = {2013},
doi = {10.18632/aging.100573},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2014
Open access · CC-BY
Altered proteome turnover and remodeling by short‐term caloric restriction or rapamycin rejuvenate the aging heart
Hospital Universitario Getafe 2019
Open access · US-GOV
Adaptation and Validation of Frailty Scales in Critically Ill Patients Admitted to Intensive Care Units in Spain
Aging Cell 2014
Open access · CC-BY
Maternal caloric restriction partially rescues the deleterious effects of advanced maternal age on offspring
Innovation in Aging 2024
Open access · CC-BY
SEX AS A BIOLOGICAL VARIABLE IN CARDIAC AGING: CORRELATIONS AMONG ECHOCARDIOGRAM, FRAILTY, AND ANESTHESIA RECOVERY
Immunity & Ageing 2023
Open access · CC-BY
Mitochondrial DNA and inflammatory proteins are higher in extracellular vesicles from frail individuals
BMC Geriatrics 2013
Open access · CC-BY